Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study

Documenti analoghi

• Thyroid and Hepatic Function After High Dose (131)I-Metaiodobenzylguanidine ((131)I-MIBG) Therapy for Neuroblastoma
  di: Quach, Alekist, et al.
  Pubblicazione: (2010)
• Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [(18)F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma
  di: Taggart, Denah R., et al.
  Pubblicazione: (2009)
• Phase I Study of Vincristine, Irinotecan, and (131)I-Metaiodobenzylguanidine ((131)I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy (NANT) Trial
  di: DuBois, Steven G., et al.
  Pubblicazione: (2012)
• Different outcomes for relapsed vs. refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)
  di: Zhou, Margaret J., et al.
  Pubblicazione: (2015)
• Phase 1 Study of Vorinostat as a Radiation Sensitizer with (131)I-Metaiodobenzylguanidine ((131)I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
  di: DuBois, Steven G., et al.
  Pubblicazione: (2015)